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Photoreceptorcelldeathisthedeﬁnitivecauseofvisionlossinretinaldetachment(RD).MammalianSTE20-likekinase(MST)isa
master regulator of both cell death and proliferation anda critical factor in development and tumorigenesis. However, to date the
role of MST in neurodegeneration has not been fully explored. Utilizing MST1
 /  and MST2
 /  mice we identiﬁed MST2, but
not MST1, as a regulator of photoreceptor cell death in a mouse model of RD. MST2
 /  mice demonstrated signiﬁcantly
decreased photoreceptor cell death and outer nuclear layer (ONL) thinning after RD. Additionally, caspase-3 activation was
attenuated in MST2
 /  mice compared to control mice after RD. The transcription of p53 upregulated modulator of apoptosis
(PUMA) and Fas was also reduced in MST2
 /  mice post-RD. Retinas of MST2
 /  mice displayed suppressed nuclear
relocalization of phosphorylated YAP after RD. Consistent with the reduction of photoreceptor cell death, MST2
 /  mice
showed decreased levels of proinﬂammatory cytokines suchas monocyte chemoattractant protein 1 and interleukin 6 as well as
attenuated inﬂammatory CD11b cell inﬁltration during the early phase of RD. These results identify MST2, not MST1, as a critical
regulator of caspase-mediated photoreceptor cell death in the detached retina and indicate its potential as a future
neuroprotection target.
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Retinal detachment (RD) occurs when the photoreceptors of
the retina become separated from the underlying retinal
pigment epithelium. RD causes photoreceptor cell death,
which leads to visual decline. The primary cause of photo-
receptor cell death in response to RD is apoptosis,
1 and Fas
signaling is a major cell death pathway activated in the
detached retina.
1–4 Several retinal disorders are associated
with RD including age-related macular degeneration,
5 diabetic
retinopathy,
6 retinopathy of prematurity,
7 as well as rhegma-
togenous RD.
8 Medical and surgical treatments for these
diseases have been improved over recent years. However,
visual acuity is not always restored after successful reattach-
ments due to the induction of photoreceptor cell death that
resulted from the RD. Only two-ﬁfths of patients with
rhegmatogenous RD involving the macula, a region essential
for central vision, recover 20/40 or better vision.
9,10 Therefore,
identiﬁcation of the mechanisms involved in photoreceptor cell
deathafterRDiscriticaltodevelopingnewtreatmentstrategies
with the aim of preserving photoreceptor cell viability.
The Mammalian Sterile 20-like kinase (MST) 1/2 are
homologs of Drosophila Hippo kinase.
11 The Hippo pathway
has been shown to have a critical role in controlling organ size
by regulating both cell proliferation and apoptosis.
12–16 Upon
activationofmammalianHippopathway,MST1/2formprotein
complex involving Salvador (SAV) 1, large tumor suppressor
(LATS) 1/2 and Mps one binder (MOB) 1, which phosphor-
ylates and inactivates Yes-associated protein (YAP).
17–19
YAP is a transcriptional coactivator, which binds to a nuclear-
localized transcription factor TEA domain family (TEAD) and
potentiates the cells proliferative and anti-apoptotic path-
ways.
20,21 Mutations in the Hippo pathway increase the levels
of functional YAP in the nucleus, which leads to the sustained
proliferating and anti-apoptotic transcriptional programs and
overcomes organ size control to promote cancer develop-
ment.
22–26 It has been reported that phosphorylated YAP
binds to 14-3-3 in cytoplasm, which leads to cytoplasmic
retention of phosphorylated YAP.
17,18 However, recent
studies revealed that phosphorylated YAP also relocalizes
into nucleus and binds to a transcription factor p73, which
exerts apoptotic activity.
27–30 Therefore, Hippo pathway
controls both cell proliferation and death through the modula-
tion in cellular localization of YAP and phosphorylated YAP.
Although the upstream regulators of mammalian Hippo
pathway have not been clariﬁed, several studies have
reported that Fas active receptor promoted the initiation of
the mammalian Hippo pathway.
28,31–33
MST1/2 have recently been suggested to mediate neuronal
cell death.
34–37 However, their precise roles in various
neurodegenerations have not been fully elucidated. In this
study, we induced experimental RD in mice deﬁcient in MST1
or MST2 in order to investigate the role of mammalian Hippo
pathway in RD-induced photoreceptor cell death.
38 Our
results indicate that MST2, not MST1, plays a critical role in
photoreceptor cell death in the detached retina.
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Expression of MST1/2 mRNA and protein in the retina.
MST1 and MST2 are ubiquitously expressed serine/threo-
nine kinases. We ﬁrst assessed if the loss of MST1 or MST2
led to upregulation of the corresponding MST protein by WB
using the whole retinas of mice without RD. MST1
 /  or
MST2
 /  mice showed no upregulation of MST2 or MST1
protein, respectively. (Figures 1a and b). Next, we checked
MST1 and MST2 mRNA expressions in photoreceptor cells
by laser capture microdissection (LCM) and reverse tran-
scriptional PCR. Complementary DNA (cDNA) from whole
retina of MST1
 /  or MST2
 /  mouse was used as a
negative control. Both MST1 and MST2 mRNAs were
expressed in outer nuclear layer (ONL), which consists of
photoreceptor cell nuclei (Figures 1c and d). Given the role of
Hippo pathway in organ development and tumorigenesis, we
wanted to assess if any morphologic changes occurred
within the retina when MST1 or MST2 was knocked out.
Histological examination showed that the absence of MST1
or MST2 protein did not result in any obvious morphologic
state under normal conditions (Figures 1e and f).
MST2 deﬁciency rescues photoreceptors from RD-
induced cell death. Given the role of the Hippo pathway
in apoptosis, we investigated the function of MST1 and 2
proteins in our experimental mouse RD model, which results
in the death of photoreceptor cells that compromise the ONL.
Our RD model shows the peak of TUNEL (TdT-dUTP
terminal nick-end labeling)-positive cells on day 1. Therefore,
we analyzed TUNEL-positive cell density in ONL at 12h, 1, 3,
5 and 7 days after RD (Figures 2a–d). Reduction in ONL
thickness was assessed as ONL/INL (inner nuclear layer)
ratio on day 7 (Figures 2e and f). MST1
 /  mice had no
signiﬁcant differences in TUNEL-positive cell density and
ONL thickness compared with control mice (Figures 2c and e).
In contrast, MST2
 /  mice demonstrated signiﬁcantly less
photoreceptor cell death than WT mice at 12h (WT:
1015±199 cells/mm
2 and MST2
 / : 376±70 cells/mm
2;
P¼0.009), 24h (WT: 1833±165 cells/mm
2 and MST2
 / :
516±126 cells/mm
2; P¼0.0001), and 72h (WT: 628±74
cells/mm
2 and MST2
 / : 294±25 cells/mm
2; P¼0.008)
after RD (Figure 2d). Moreover, MST2
 /  mice displayed
signiﬁcantly higher ONL/INL ratio than control mice (WT:
1.65±0.04 and MST2
 / : 1.83±0.04; P¼0.017;
Figure 2f). These results indicate that MST2 plays a critical
role in initiating RD-induced photoreceptor cell death.
MST2 deﬁciency attenuates cell death signaling after
RD. The ﬁnal step of MST pathway is phosphorylation of
Figure 1 MST1 and MST2 expressions in the retina. (a and b) Western blot analysis for MST1 and MST2 in the retina. MST1 or MST2 protein is deleted in MST1
 /  or
MST2
 /  mice,respectively.BothstrainsshownoupregulationofthecorrespondingMSTproteins.(candd)ReversetranscriptionalPCRforMST1(c)orMST2(d)inouter
nuclearlayer.MST1
 /  orMST2
 /  wholeretinawasusedasanegativecontrol.MST1orMST2mRNAisexpressedinphotoreceptorcellsinB6129SF2orC57BL/6mice,
respectively. (e and f) Retinal histology of untreated B6129F2 and MST1
 /  mice (e), or C57BL/6 and MST2
 /  mice (f). MST1
 /  and MST2
 /  mice display normal
phenotype
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Cell Death and DiseaseYAP. It is generally believed that phosphorylated YAP binds
to 14-3-3 leading to cytoplasmic retention, which decreases
YAP nuclear localization and YAP/TEAD transcriptional
activity.
17–19 However, recent studies reported that phos-
phorylated YAP might be able to relocalize into nucleus and
bind to p73 in the cell undergoing cell death.
27–30 To evaluate
the nuclear localization of phosphorylated YAP after RD, we
performed nuclear extraction followed by WB using the whole
retina at 24h after RD. MST2
 /  mice showed less
phosphorylated YAP in the nucleus compared with WT mice
(Figure 3a). We further assessed the binding between
phosphorylated YAP and p73 as well as between YAP and
TEAD after RD by immunoprecipitation and subsequent WB
analysis (Supplementary Figure S1). Consistent with the
nuclear localization of phosphorylated YAP, MST2
 /  mice
displayed less p73 binding phosphorylated YAP than WT
mice. Unexpectedly, TEAD binding YAP was also less in
MST2
 /  than WT mice, which might reﬂect the fewer
proliferating cells in the detached retina such as microglia in
MST2
 /  mice.
p73 has been reported to induce transcriptional upregula-
tion of p53 upregulated modulator of apoptosis (PUMA),
which in turn provokes BAX mitochondrial translocation and
cytochrome c release.
28,39 Moreover, a previous study
revealed that p73 activation induces upregulation of Fas
transcription and expression at cell surface.
40 On the other
hand, YAP activation was reported to induce a high expres-
sion of cIAP1 and Survivin, members of the inhibitor of
apoptosis protein (IAP) family.
22,41,42 Thus we evaluated
PUMA and Fas as well as cIAP1 and Survivin gene
transcriptions at 24h after RD. Consistent with the results of
immunoprecipitation, MST2
 /  mice showed signiﬁcantly
less PUMA (45% of WT, P¼0.009) and Fas (64% of WT,
P¼0.026) mRNA expression after RD compared with WT
Figure2 MST2,butnotMST1,mediatesphotoreceptorcelldeathafterRD.(a–d)TUNEL(green)andTO-PRO-3(blue)stainingat24hafterRD(aandb)andtimecourse
of TUNEL-positive cell density inouter nuclear layer (ONL; n¼6 each group and time point, c and d). There were no signiﬁcant differences between B6129SF2 and MST1
 / 
mice at any time points (c). Conversely, MST2
 /  mice displayed signiﬁcantly less photoreceptor cell death than C57BL/6 mice 12, 24, 72h after RD (**Po0.01 each, d).
(eandf)ONL/INL(innernuclearlayer)ratio7daysafterRD(n¼6each).TherewasnosigniﬁcantdifferencebetweenB6129SF2andMST1
 /  mice(e).Ontheotherhand,
MST2
 /  mice showed signiﬁcantly higher ONL/INL ratio than C57BL/6 mice (*Po0.05) (f). The graphs show mean±S.E.M.
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Cell Death and Diseasemice, whereas there were reduction trends that did not reach
statistical signiﬁcant differences in cIAP1 and Survivin mRNA
expressions in MST2
 /  mice (Figures 3b–e), indicating that
phosphorylated YAP/p73-mediated cell death signaling is
substantially attenuated in MST2
 /  mice.
Finally,weassessedcleavedcaspase-3proteinexpression
at 24h after RD. Cleaved caspase-3 is one of effector
caspases, which is the downstream of Fas receptor—
mediated apoptotic pathway and mitochondrial apoptotic
pathway.
2 In accordance with our expectation, cleaved
caspase-3 protein level in MST2
 /  mice after RD was
signiﬁcantly decreased compared with that of WT mice
(P¼0.011; Figure 3f), suggesting that MST2 mediates
caspase-dependent photoreceptor apoptosis in the detached
retina.
Reduced proinﬂammatory cytokine generation and
macrophage inﬁltration in MST2
 /  mice after RD. We
previously described that monocyte chemoattractant protein
1 (MCP-1) is an essential mediator of early inﬁltration of
Figure 3 MST2 promotesnuclearrelocalization ofphosphorylatedYAPandmediatesapoptosissignalingafterRD.(a)WesternblotanalysisforphosphorylatedYAPand
totalYAPintheretinaat24hafterRDusingnuclearandcytoplasmicfractions.MST2
 /  micedisplayedlessnuclearlocalizationofphosphorylatedYAPaswellastotalYAP
than WT mice after RD. TBP and b-tubulin were monitored as markers for the purity of the nuclear and cytoplasmic fractions, respectively. Representative images from three
independent experiments are shown. (b–e) Quantitative real-time PCR analysis for PUMA (b), Fas (c), cIAP1 (d) and Survivin (e) in the retina at 24h after RD (n¼6 each).
MST2
 /  mice showed signiﬁcantly less PUMA (**Po0.01) and Fas (*Po0.05) mRNA expression than WT mice, whereas there were no signiﬁcant differences in cIAP1
and Survivin mRNA expressions. (f) Western blot analysis for cleaved caspase-3 in the retina at 24h after RD (n¼6 each). MST2
 /  mice displayed signiﬁcantly less
cleaved caspase-3 than WT mice (**Po0.05). The bar graphs indicate the relative level of cleaved caspase-3 to b-actin by densitometric analysis. Each sample for western
blot analysis includes at least six retinas. Bl.6¼Wild type (WT). The graphs show mean±S.E.M.
MST2 not MST1 mediates RD-induced photoreceptor cell death
H Matsumoto et al
4
Cell Death and Diseasemacrophage/microglia after RD.
43 Zacks et al.
44 described
that interleukin 6 (IL-6) is increased after RD using gene
microarray analysis.
44 IL-6 is a pleiotropic cytokine with a role
in inﬂammation as well as hematopoiesis, angiogenesis, cell
differentiation and neuronal survival. Thus, we evaluated
MCP-1 and IL-6 expression levels by enzyme-linked immu-
nosorbent assay (ELISA). MST2
 /  mice demonstrated
signiﬁcantly less MCP-1 (WT: 253±18 pg/mg and MST2
 / :
194±2 pg/mg; P¼0.035) and IL-6 (WT: 21.3±2.2 pg/mg
and MST2
 / : 12.6±0.9 pg/mg; P¼0.014) levels than WT
mice at 24h after RD. MCP-1 and IL-6 levels were rapidly
decreased after day 1 in both groups (Figures 4a and b). We
next analyzed the inﬂammatory reaction by immunoﬂuores-
cence detection of the macrophage/microglial marker
CD11b. MST2
 /  mice showed signiﬁcantly less CD11b-
positive cell density than WT mice at 24h after RD (WT:
161±17 cells/mm
2 and MST2
 / :8 5 ±9 cells/mm
2;
P¼0.007). WT mice kept the CD11b-positive cell density
after day 1, whereas that in MST2
 /  mice was increased to
the same level as WT mice 3 days after RD (Figures 4c and d).
These results indicate that MST2 mediates the inﬂammation
during the early phase of RD.
Discussion
MST1/2 are ubiquitously expressed and known for their
function in promoting cell death. MST is critical for organ
development and tumorigenesis suppression.
12–16,22–26
Recently, mammalian Hippo pathway has been implicated in
playing a role in neurodegeneration,
34–37 however, the
functional differences between MST1 and MST2 in various
neurodegenerations have not been well explored. Thus, we
investigated the role of MST1/2 in photoreceptor cell death
using a mouse RD model. We induced RD in mice deﬁcient in
MST1 or MST2 and evaluated photoreceptor cell death.
In contrast to Lee et al.
37 MST1 deletion had no effect on
RD-induced neuronal cell death, whereas MST2 deletion
signiﬁcantly attenuated photoreceptor cell death after RD
(Figure 2) and subsequent inﬂammatory response including
MCP-1 and IL-6 secretion as well as CD11b-positive cell
inﬁltration (Figure 4). Therefore, we deﬁne the involvement of
MST2, but not MST1, as a regulator of photoreceptor cell
death after RD. Both MST1
 /  and MST2
 /  mice show
normal retinal phenotype (Figures 1e and f), suggesting that
single deﬁciency of MST1 or MST2 does not affect the normal
retinal development.
Upon activation, MST1/2 form protein complex involving
SAV1, LATS1/2 and MOB1, which phosphorylates YAP. It is
generally believed that phosphorylated YAP binds to 14-3-3
leadingtocytoplasmicretention,which decreasesYAP/TEAD
nuclear complex and its transcriptional activity.
17–19 However,
recently, several investigators reported that phosphorylated
YAP might be able to relocalize into nucleus and bind to p73
under cell death stimulations and potentiate p73 apoptotic
activity.
27–30 Accumulating evidences also indicate that Fas
signaling may modulate the activity of mammalian Hippo
pathway.Moreover,Fassignalingiswellknowntobeinvolved
in photoreceptor cell death after RD.
1–4 Consistent with these
reports, nuclear localization of phosphorylated YAP after RD
was suppressed in MST2
 /  mice in the current study
(Figure 3a). Furthermore, p73 binding phosphorylated YAP
was reduced in MST2
 /  mice after RD (Supplementary
Figure S1). These results indicate that MST2 plays a critical
role in nuclear relocalization of phosphorylated YAP and
subsequent p73 binding after RD.
Matallanas et al.
28 reported that p73–YAP1 complex
directly enhanced transcription of PUMA gene. Consistent
with this report, PUMA mRNA expression was signiﬁcantly
attenuated in MST2
 /  mice after RD (Figure 3b). PUMA is a
Bcl-2 family member/BH3-only protein, which exists in the
cytosol in unstressed cells and accumulates onto the
mitochondrial membrane upon death stimuli. PUMA mediates
Bax (Bcl-2 family member/Bax subfamily) translocation from
cytosol into mitochondria, thus leading to cytochrome c
release and caspase activation.
39 p73 activation is also
reported to induce upregulation of Fas transcription and
expression at cell surface.
40 In accordance with this report,
Fas mRNA expression was signiﬁcantly suppressed in
MST2
 /  mice after RD (Figure 3b). Fas is one of death
receptors, which mediates mainly apoptotic signaling. Fas
signaling will increase cleaved caspase-3 level through
receptor-mediatedapoptoticpathwayaswellasmitochondrial
apoptotic pathway.
2 Moreover, increased Fas signaling will
enhance the activation of mammalian Hippo pathway, which
might result in the positive feedback loop. As expected from
reduced PUMA and Fas mRNA expression, MST2
 /  mice
showed signiﬁcantly lower cleaved caspase-3 protein expres-
sion compared with WT mice after RD (Figure 3f). Taken
together, our data indicate MST2 mediates RD-induced
photoreceptor cell death in caspase-dependent manner.
We expected that WT mice would show less TEAD binding
YAP than MST2
 /  mice after RD, because YAP is reported
to translocate from nucleus to cytoplasm under the activation
of mammalian Hippo pathway. However, TEAD binding YAP
was elevated in WT mice compared with MST2
 /  mice
(Supplementary Figure S1), whereas there were reduction
trends that did not reach statistical signiﬁcant differences in
cIAP1 and Survivin mRNA expressions (Figures 3d and e),
which are reported to increase under YAP activation. It has
been known that several types of retinal cells including
microglia, Mu ¨ller cell and astrocyte, proliferate after RD,
45–49
in which YAP might be activated and mediate proliferative and
anti-apoptotic signaling. In the current study, microglial
proliferation in the detached retina was more marked in WT
than MST2
 /  mice 24h after RD (Figures 4c and d). This
might result in the higher YAP/TEAD binding in WT mice
because whole retina was used for the immunoprecipitation
assay.
In contrast to MST2
 /  mice, MST1
 /  mice showed no
protective effect on photoreceptor cell death after RD in this
study (Figure 2). MST2 shares 98% identity with MST1 in the
catalytic domain, but only 60% in the regulatory region.
50 It
also shares more homology than MST1 with Hippo.
51 More-
over, MST1/2 expression proﬁle depends on the cell type.
52
Although both MST1 and MST2 are ubiquitously expressed,
these differences might lead to the functional difference
between MST1 and MST2 in photoreceptor cell death after
RD. Fas signaling is reported to activate MST2 via activation
of Ras-association domain family 1 and subsequent inhibition
of rapidly accelerated ﬁbrosarcoma (RAF) 1.
28 Proteomic
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Cell Death and Diseasestudies have identiﬁed several protein kinases that copreci-
pitate with RAF1 including MST2 but not MST1.
53–56 This can
be an explanation for the difference in protective effect on
photoreceptor cell death after RD between MST1
 /  and
MST2
 /  mice. In contrast with our results, Lee et al.
37
recently reported thatMST1 mediates neurodegeneration in a
mouse model of amyotrophic lateral sclerosis (ALS).
37 This
difference may relate to the cell type involved (photoreceptors
Figure 4 MST2 promotes inﬂammatory response after RD. (a and b) ELISA to detect MCP-1 (a) and IL-6 (b) in the WT and MST2
 /  retinas at 24, 48, 72h after RD
(n¼8each). MCP-1andIL-6generationat 24hafterRD was suppressed in MST2
 /  mice(*Po0.05). Afterday1, MCP-1andIL-6levelsweredecreasedinbothgroups.
(c and d) Immunoﬂuorescence for CD11b (c) and time course of CD11b-positive cell density (d) in WT and MST2
 /  mice (n¼6 each group and time point). Inﬁltration of
CD11b-positive cells was substantially decreased in MST2
 /  mice at 24h after RD (**Po0.01). WT mice kept the CD11b-positive cell density after day 1, whereas that in
MST2
 /  mice was increased to the same level as WT mice 3 days after RD. The graphs show mean±S.E.M.
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Cell Death and Diseaseversus motor neurons) and/or the triggers of neuronal cell
death. They described that MST1 modulates oxidative stress-
initiated neurodegeneration. Oxidative stress is also one of
important triggers in photoreceptor cell death after RD,
1,57,58
however the intensity and duration of the oxidative stress may
differ when compared to the ALS model.
Wepreviously reported thatMCP-1isanessentialmediator
of early inﬁltration of macrophage/microglia after RD.
43 In
accordance with this, MST2
 /  mice, whose photoreceptor
cell death and MCP-1 levels were signiﬁcantly lower than
those of WT mice, showed signiﬁcantly less CD11b-positive
cell density at 24h after RD. However, MCP-1 and IL-6 levels
were decreased after day 1, whereas CD11b-positive cell
density was kept at high level in the late phase of RD in both
groups (Figure 4). These results indicate that other chemo-
tactic factors might be involved in the late phase of
macrophage/microglia inﬁltration. In addition, recent studies
disclosed that macrophage is divided into two types (M1/M2)
depending on its function.
59–61 The M1 macrophages express
high levels of proinﬂammatory cytokines, and produce
reactive nitrogen and oxygen intermediates. In contrast, M2
macrophages have immunoregulatory functions and promote
tissue remodeling. They are also characterized by efﬁcient
phagocytic activity and high expression of scavenging
molecules. It is possible that the macrophage/microglia in
the early and the late phase of RD might be of different class.
Necrotic photoreceptor cell death is known to occur after
RD and other retinal photoreceptor degenerations, although
its frequency is approximately half that of apoptosis.
1,62 It has
been reported that necrotic cells release damage-associated
molecular patterns (DAMPs) and enhance inﬂammatory
response.
63–65 DAMPs activate macrophages as Toll-like
receptor ligands. The activated macrophages then release
inﬂammatory cytokines such as IL-1, 6 and 8.
66,67 In the
currentstudy,IL-6levelwasconsistentwithphotoreceptorcell
death and CD11b-positive cell density at 24h after RD,
suggesting that IL-6 might be derived mainly from DAMPs
activated macrophages.
In conclusion, we investigated the role of mammalian Hippo
pathway in neurodegeneration using a mouse RD model. In
contrast to prior reports in neurodegenration, MST1 did not
appear to play a role in photoreceptor degeneration after RD.
However, MST2 was identiﬁed as a critical mediator in RD-
induced photoreceptor cell death. Blockade of MST2 may
suppress photoreceptor cell death and dampen early inﬂam-
mation, suggesting that MST2 may be a potential target for
retinal degenerative diseases associated with RD and
inﬂammation.
Materials and Methods
Animals. All animal experiments followed the guidelines of the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research, and the
protocols were approved by the Animal Care Committee of the Massachusetts Eye
and Ear Inﬁrmary. We generated MST1
 /  and MST2
 /  mice and their details
were described previously.
24 The background of MST1
 /  or MST2
 /  mouse
used in this study is B6129 or C57BL/6 mouse, respectively. Age- and gender-
matched B6129SF2 or C57BL/6 mice were purchased from Jackson Laboratories
(Bar Harbor, ME, USA) or Charles River Laboratories (Wilmington, MA, USA),
respectively. Mice were fed standard laboratory chow and allowed free access to
water in an air-conditioned room with a 12-h light/12-h dark cycle. All mice were
used at postnatal 8±1 weeks.
Creation of RD. We modiﬁed a previously reported method for creating RDs
and created bullous and persistent RDs.
38 Brieﬂy, mice were anesthetized with an
intraperitoneal injection of a mixture of 60mg/kg ketamine and 6mg/kg xylazine,
and pupils were dilated with topical phenylephrine (5%) and tropicamide (0.5%).
The temporal conjunctiva at the posterior limbus was incised and detached from
the sclera. A 30-gauge needle (BD, Franklin Lakes, NJ, USA) was used with the
bevel pointed up to create a sclerotomy 1mm posterior to the limbus. A scleral
tunnel was created followed by scleral penetration into the choroid, which makes a
self-sealing scleral wound. A corneal puncture was made with a 30-gauge needle
to lower intraocular pressure. Then a 34-gauge needle connected to a 10-ml
syringe (NanoFil 10ml syringe; WPI, Sarasota, FL, USA) with the bevel pointed
down was inserted into the subretinal space and 4ml of 1% sodium hyaluronate
(Provisc; Alcon, Fort Worth, TX, USA) was injected gently to detach the
neurosensory retina from the underlying RPE. Approximately 60% of the temporal-
nasal neurosensory retina was detached. Finally, cyanoacrylate surgical glue
(Webglue; Patterson Veterinary, Devens, MA, USA) was put on the scleral wound
and the conjunctiva was reattached to the original position. Any eyes with
subretinal hemorrhage were excluded from the study.
TUNEL. Following RD, eyes were enucleated at multiple time points and
embedded in OCT compound (Tissue Tek; Sakura Finetec, Torrance, CA, USA).
Serial sections of the eyes in the sagittal plane were cut at 10mm thickness on a
cryostat (CM1850; Leica, Heidelberg, Nussloch, Germany) at  201C and
prepared for staining. TUNEL assay was performed according to the manufacturer’s
protocol (ApoTag Fluorescein In Situ Apoptosis Detection Kit; Millipore, Billerica,
MA, USA). Finally, sections were counterstained with TO-PRO-3. The number of
TUNEL-positive cells was counted in the photoreceptor cell layer (ONL). The area
of ONL was also measured by Image J software (developed by Wayne Rasband,
National Institutes of Health, Bethesda, MD, USA; available at http://rsb.info.nih.
gov/ij/index.html), and then TUNEL-positive cell density in ONL was calculated. A
preliminary experiment revealed that the center of RD had less variability of
TUNEL-positive cell density (data not shown). Thus subsequent analysis was
performed using sections around 1000mm from the injection site. The average of
the TUNEL-positive cell density from two separate locations of each section (see
Supplementary Figure S2) was calculated as the representative TUNEL-positive
photoreceptor cell density of the section. Then, the average of the TUNEL-positive
photoreceptor cell densities from three sections was ﬁgured as the representative
TUNEL-positive photoreceptor cell density of the eye. Photographs were taken by
confocal microscopy using a HCX APOL 40  lens (Leica, Allendale, NJ, USA).
Evaluation of ONL/INL ratio. The ONL and INL areas of the detached
retina were measured by Image J software and ONL/INL ratio was calculated.
Areas of abnormal retinal morphology were excluded so that uniform unbiased
measurements can be obtained.
Western blot analysis. Whole retina from untreated or RD-induced eye was
dissected from the RPE choroid. Total retinal lysate was used to evaluate MST1,
MST2 and cleaved caspase-3 expressions. Nuclear and cytoplasmic extraction was
performed according to the manufacturer’s protocol (Nuclear Extract Kit; Active Motif
North America, Carlsbad, CA, USA) to assess nuclear YAP and phosphorylated
YAP expression. At least six retinas were used for each sample. Samples were run
on 4–12% Bis-Tris gel (NuPAGE; Invitrogen, Camarillo, CA, USA) electrophoresis
and transferred onto PVDF membranes (0.45 mm pores; Millipore, Billerica, MA, USA).
After blocking with 3% nonfat dried milk, the membranes were incubated overnight
with primary antibody (MST1, YAP, phosphorylated YAP, Cleaved Caspase-3,
b-actin, b-tubulin: 1:1000 (Cell Signaling, Danvers, MA, USA), MST2: 1:10000,
TBP: 1:2000 (Abcam, Cambridge, MA, USA)). The blotted membranes were then
incubated for 30min at room temperature with HRP-labeled secondary antibody.
Immunoreactive bands were visualized by ECL and detected by ChemiDoc MP
Imaging System (Hercules, CA, USA).
Immunoprecipitation. Equal amount of retinal lysates (1mg) were
incubated with 25mg of protein A agarose beads (Cell Signaling) for 1h to
remove non-speciﬁc protein binding. The supernatants were then incubated with
3mg anti-p73 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or 5mg
anti-TEF-1 antibody (BD Biosciences, San Jose, CA, USA) for 2h, followed by
incubation with 25mg of protein A agarose for 3h. Each incubation was done at
41C. Beads were washed ﬁve times with lysis buffer and the immunopellets were
then subjected to western blotting.
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after enucleation, cut into 30-mm sections, and collected on RNase-free
polyethylene naphthalate membrane slides (Leica). Sections were stained with
0.1% toluidine blue, dehydrated with both 50 and 75% ethanol, and air dried. ONL
was microdissected on a LCM system (LMD-7000; Leica).
Measurement of mRNA expression by real-time PCR. Whole retina
or ONL dissected by LCM were used for PCR. Total RNA was harvested using the
RNeasy Kit (Qiagen, Valencia, CA, USA). cDNA was generated with Oligo-dT
primer (Invitrogen) and Superscript II (Invitrogen) according to the manufacturer’s
instructions. Real-time PCR was carried out using the following TaqMan gene
expression assays (Applied Biosystems, Foster City, CA, USA): MST1
(Mm00451755_m1), MST2 (Mm01168119_m1), PUMA (Mm00519268_m1), Fas
(Mm01204974_m1), actin (Mm00607939_s1). Quantitative expression data were
acquired and analyzed with a Step One Plus real-time PCR system (Applied
Biosystems).
ELISA. The levels of MCP-1 and IL-6 were determined with mouse MCP-1 and
IL-6 ELISA kits (R&D Systems, Minneapolis, MN, USA), according to the
manufacturer’s protocol.
Immunohistochemistry. Sections were ﬁxed in acetone for 5min, blocked
in 2% skim milk for 20min, and incubated with rat anti-CD11b antibody (1:50; BD
Biosciences) at 41C overnight. Alexa Fluor 488-conjugated goat anti-rat IgG was
used as a secondary antibody and incubated at room temperature for 30min.
Finally, sections were counterstained with TO-PRO-3.
Statistical analysis. The results are expressed as the mean±SE. Statistical
analysis was performed nonparametrically with Mann–Whitney U-test. The
signiﬁcance level was set at Po0.05 (* in ﬁgures) and Po0.01 (** in ﬁgures).
Statistical analysis and graphing were performed using Prism Ver.5.
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